Alignment Healthcare, Inc. (NASDAQ:ALHC) Insider Hakan Kardes Sells 10,500 Shares

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) insider Hakan Kardes sold 10,500 shares of the company's stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $14.99, for a total transaction of $157,395.00. Following the transaction, the insider now directly owns 309,944 shares of the company's stock, valued at approximately $4,646,060.56. This trade represents a 3.28 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link.

Hakan Kardes also recently made the following trade(s):

• On Wednesday, November 27th, Hakan Kardes sold 35,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $12.80, for a total value of $448,000.00.
• On Monday, November 4th, Hakan Kardes sold 20,500 shares of Alignment Healthcare stock. The stock was sold at an average price of $13.06, for a total value of $267,730.00.
• On Friday, November 1st, Hakan Kardes sold 4,500 shares of Alignment Healthcare stock. The shares were sold at an average price of $12.98, for a total transaction of $58,410.00.

Alignment Healthcare Stock Performance

ALHC stock traded down $0.04 on Thursday, hitting $14.57. The company had a trading volume of 1,177,627 shares, compared to its average volume of 1,850,902. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 1.82. Alignment Healthcare, Inc. has a 12-month low of $4.46 and a 12-month high of $15.03. The stock has a market cap of $2.79 billion, a price-to-earnings ratio of -18.92 and a beta of 1.45. The stock's 50-day simple moving average is $12.03 and its 200 day simple moving average is $10.92.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last issued its quarterly earnings data on Tuesday, October 29th. The company reported ($0.14) EPS for the quarter, hitting the consensus estimate of ($0.14). Alignment Healthcare had a negative return on equity of 108.69% and a negative net margin of 5.84%. The company had revenue of $692.43 million during the quarter, compared to analyst estimates of $662.11 million. During the same quarter in the previous year, the company posted ($0.19) earnings per share. Alignment Healthcare's revenue was up 51.6% compared to the same quarter last year. As a group, equities research analysts expect that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Alignment Healthcare

A number of institutional investors and hedge funds have recently made changes to their positions in ALHC. Creative Planning lifted its holdings in Alignment Healthcare by 20.0% during the third quarter. Creative Planning now owns 12,442 shares of the company's stock valued at $147,000 after purchasing an additional 2,072 shares in the last quarter. R Squared Ltd purchased a new position in shares of Alignment Healthcare during the 4th quarter valued at $55,000. SG Americas Securities LLC boosted its holdings in Alignment Healthcare by 11.7% in the 4th quarter. SG Americas Securities LLC now owns 49,272 shares of the company's stock worth $554,000 after buying an additional 5,163 shares during the period. nVerses Capital LLC bought a new stake in Alignment Healthcare during the third quarter valued at about $95,000. Finally, The Manufacturers Life Insurance Company lifted its position in shares of Alignment Healthcare by 20.9% in the second quarter. The Manufacturers Life Insurance Company now owns 55,531 shares of the company's stock valued at $434,000 after acquiring an additional 9,595 shares in the last quarter. Hedge funds and other institutional investors own 86.19% of the company's stock.

Analyst Upgrades and Downgrades

ALHC has been the subject of several research analyst reports. Stephens reaffirmed an "overweight" rating and issued a $17.00 target price on shares of Alignment Healthcare in a research report on Thursday, January 2nd. UBS Group raised their price objective on shares of Alignment Healthcare from $9.00 to $12.00 and gave the stock a "neutral" rating in a report on Wednesday, October 30th. KeyCorp started coverage on Alignment Healthcare in a research report on Friday, October 11th. They set a "sector weight" rating on the stock. Barclays boosted their price objective on shares of Alignment Healthcare from $7.00 to $8.00 and gave the stock an "underweight" rating in a research note on Wednesday, October 30th. Finally, Stifel Nicolaus raised their target price on shares of Alignment Healthcare from $14.00 to $16.00 and gave the company a "buy" rating in a research note on Tuesday, January 14th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $11.88.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.